Future Journal of Pharmaceutical Sciences

Table 1 Composition of gliclazide SMEDDS batches (M1 to M8)

From: Enhancement of in vivo hypoglycemic effect of gliclazide by developing self-microemulsifying pellet dosage form

Batch	Oil (% v/v)	Surfactant (% v/v)	Co-surfactant (% v/v)
M1	12.50	70.00	17.50
M2	21.43	62.86	15.71
M3	16.67	66.67	16.67
M4	28.57	57.14	14.29
M5	10.42	60.42	29.17
M6	15.63	56.25	28.13
M7	11.27	59.15	29.58
M8	12.24	59.18	28.57

Back to article page